CSSL LTD

Active Scunthorpe
2 employees website.com
Healthcare and wellbeing
C

CSSL LTD

Founded 18 May 2000 Active Scunthorpe, England 2 employees website.com
Healthcare and wellbeing

Previous Company Names

CLINICAL SOFTWARE SOLUTIONS LIMITED 9 Sept 2011 — 7 Apr 2015
SURGEONS NET LIMITED 18 May 2000 — 9 Sept 2011
Accounts Submitted 4 Aug 2025 Next due 31 Dec 2026 8 months remaining
Confirmation Submitted 26 Jun 2025 Next due 10 Jul 2026 2 months remaining
Net assets £158K £104K 2024 year on year
Total assets £179K £93K 2024 year on year
Total Liabilities £20K £12K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Normanby Gateway Lysaghts Way Scunthorpe South Humberside DN15 9YG England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CSSL LTD (03996773), an active healthcare and wellbeing company based in Scunthorpe, England. Incorporated 18 May 2000. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£36.32k

Net Assets

£158.45k

Increased by £104.21k (+192%)

Total Liabilities

£20.38k

Decreased by £11.70k (-36%)

Turnover

N/A

Employees

2

Increased by 1 (+100%)

Debt Ratio

11%

Decreased by 26 (-70%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Zarin DasturDirectorBritishEngland846 Nov 2019Active

Shareholders

Shareholders (1)

Neville Behram Dastur
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Neville Behram Dastur

British

Active
Notified 1 May 2017
Residence England
DOB December 1973
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Emma Dastur

Ceased 16 Oct 2019

Ceased

Group Structure

Group Structure

CSSL LTD Current Company
MHS VASCULAR LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
4 Aug 2025AccountsAnnual accounts made up to 2025-03-31
26 Jun 2025Confirmation StatementConfirmation statement made on 2025-06-26 with no updates
29 May 2025AccountsAnnual accounts made up to 2024-03-31
21 Apr 2025OfficersChange to director Mr Neville Behram Dastur on 2025-04-10
28 Feb 2025AccountsAnnual accounts made up to 2024-05-31
4 Aug 2025 Accounts

Annual accounts made up to 2025-03-31

26 Jun 2025 Confirmation Statement

Confirmation statement made on 2025-06-26 with no updates

29 May 2025 Accounts

Annual accounts made up to 2024-03-31

21 Apr 2025 Officers

Change to director Mr Neville Behram Dastur on 2025-04-10

28 Feb 2025 Accounts

Annual accounts made up to 2024-05-31

Recent Activity

Latest Activity

Annual accounts made up to 2025-03-31

8 months ago on 4 Aug 2025

Confirmation statement made on 2025-06-26 with no updates

10 months ago on 26 Jun 2025

Annual accounts made up to 2024-03-31

11 months ago on 29 May 2025

Change to director Mr Neville Behram Dastur on 2025-04-10

1 years ago on 21 Apr 2025

Annual accounts made up to 2024-05-31

1 years ago on 28 Feb 2025